anirolac
Also Known As:
2,3-dihydro-5-(4-methoxybenzoyl)-1H-pyrrolizine-1-carboxylic acid; RS 37326
Networked: 1
relevant articles (0 outcomes,
1 trials/studies)
Bio-Agent Context: Research Results
Related Diseases
| 1. | Pain (Aches)
07/01/1987
- " In a stratified, randomized, parallel, double-blind trial, 120 hospitalized women with moderate or severe postpartum uterine pain were treated with single oral doses of anirolac, 50 or 100 mg, naproxen sodium, 550 mg, or placebo. " 07/01/1987
- " Anirolac vs. naproxen for postpartum uterine pain." 07/01/1987
- " Our results suggest that, for postpartum uterine pain, analgesia with anirolac, 50 or 100 mg, is equivalent to that with naproxen, 550 mg."
|
|
Related Drugs and Biologics
Related Therapies and Procedures